awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38612965-260FDA02-3FB0-41F1-B51D-25C14BEB5EEE
Q38612965-260FDA02-3FB0-41F1-B51D-25C14BEB5EEE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38612965-260FDA02-3FB0-41F1-B51D-25C14BEB5EEE
The Emerging Role of PD-1/PD-L1-Targeting Immunotherapy in the Treatment of Metastatic Urothelial Carcinoma.
P2860
Q38612965-260FDA02-3FB0-41F1-B51D-25C14BEB5EEE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38612965-260FDA02-3FB0-41F1-B51D-25C14BEB5EEE
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e1f5eb759add7fabc14ea034620fd113d517919d
P2860
Safety and Efficacy of Durvalumab (MEDI4736), an Anti-Programmed Cell Death Ligand-1 Immune Checkpoint Inhibitor, in Patients With Advanced Urothelial Bladder Cancer.